Cargando…
Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
Expanded access is a regulatory mechanism by which an investigational drug can be made available outside of a clinical trial to treat patients with serious or life-threatening conditions for which there are no satisfactory treatment options. An expanded access program (EAP) is the formal plan under...
Autores principales: | Klopfenstein, Mitchell, Van Campen, Luann E., Garnett, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802520/ https://www.ncbi.nlm.nih.gov/pubmed/29473010 http://dx.doi.org/10.1177/2168479015578154 |
Ejemplares similares
-
Ethics of sponsored research
por: Mandal, Jharna, et al.
Publicado: (2014) -
Conducting focus groups in neurodegenerative disease populations: ethical and methodological considerations
por: Jones, Annabel, et al.
Publicado: (2021) -
Ethical issues in the access to emergency care for undocumented immigrants
por: Brenner, Jay M., et al.
Publicado: (2021) -
Considerations for applying bioethics norms to a biopharmaceutical industry setting
por: Van Campen, Luann E., et al.
Publicado: (2021) -
Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees
por: Li, Rebecca H, et al.
Publicado: (2016)